Capital Increase / Dilution2026-06-22

Decision on Issuance of Convertible Bonds

CHA

아리바이오LAB

261780

-0.50

Signal Score

52CNeutral
Score52 / 100

Historical Avg Return (5d)

+0.33%

Data Coverage

100%n=2377

Risk-adjusted indicator based on 2377 historical DART filings. For informational purposes only — not investment advice.

Financial Impact

NEGATIVE

Key Numbers

  • • Event Type: Issuance of Convertible Bonds

AI Analysis Summary

CHA Vaccine Research Institute announced a decision to issue convertible bonds. This typically signals potential future dilution for existing shareholders upon conversion, which can negatively impact per-share value. The specific terms, such as conversion price and total issuance amount, would determine the exact dilution rate and overall financial impact. The purpose of the funds raised would also be a key factor in assessing the long-term implications.

Track Korean Market Signals — Free

Sign up free to access live disclosures, AI analysis, and event filters.

Public Beta · No credit card required

This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.

AI-processed analysis. Based on: [첨부정정]주요사항보고서(전환사채권발행결정). Source: Financial Supervisory Service (금융감독원 전자공시시스템). Raw government data is not redistributed. Not investment advice.